Page last updated: 2024-10-14

gb-115

Cross-References

ID SourceID
PubMed CID11281948
MeSH IDM0511045

Synonyms (14)

Synonym
gb-115
l-tryptophanamide, n-(1-oxo-6-phenylhexyl)glycyl-
678996-63-9
DTXSID70461104
n-(6-phenylhexanoyl)glycyl-l-tryptophan amide
unii-g5yt2f7sg8
G5YT2F7SG8 ,
n-(2-((1-amino-3-(1h-indol-3-yl)-1-oxopropan-2-yl)amino)-2-oxoethyl)-6-phenylhexanamide
gb115
(-)-gb-115
n-(1-oxo-6-phenylhexyl)glycyl-l-tryptophanamide
n-[2-[[(2s)-1-amino-3-(1h-indol-3-yl)-1-oxopropan-2-yl]amino]-2-oxoethyl]-6-phenylhexanamide
(s)-n-(2-((1-amino-3-(1h-indol-3-yl)-1-oxopropan-2-yl)amino)-2-oxoethyl)-6-phenylhexanamide
EX-A7817

Pharmacokinetics

ExcerptReference
" Pharmacokinetic parameters were calculated after intravenous and peroral administration of GB-115."( Experimental study of the pharmacokinetics of a tryptophan-containing dipeptide GB-115.
Boyko, SS; Gudasheva, TA; Kiryanova, EP; Kolyvanov, GB; Seredenin, SB; Zherdev, VP, 2007
)
" In contrast to crystalline, the micronized substance exhibited better pharmacokinetic parameters and higher bioavailability."( [EXPERIMENTAL PHARMACOKINETICS AND PHARMACODYNAMICS OF GB-115 DIPEPTIDE ANXIOLYTIC SUBSTANCES].
Boiko, SS; Gudasheva, TA; Kolik, LG; Konstantinopol'skii, MA; Mart'yanov, VA; Raskin, SY; Seredenin, SB; Zherdev, VP, 2015
)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (20.00)29.6817
2010's11 (73.33)24.3611
2020's1 (6.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other17 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]